"We need to learn a good deal more about the mechanism by which a microbial population changed by gastric bypass exerts its effects, " said study author Dr Lee Kaplan, an associate professor of Medicine at Harvard Medical School.
The companies pressed ahead into trials even as evidence emerged that cancer cells had bypass mechanisms that would allow the tumors to sidestep the drugs' effects.